Amend Surgical is focused on the development and commercialization of novel materials for the oral surgical and dental market. In 2020, Amend Surgical licensed the exclusive rights for a novel, tough, surgical adhesive for dental and oral surgical applications from the Wyss Institute at Harvard University. Amend Tissue Tape™ is a wound and barrier technology that forms long lasting ionic and covalent bonds that tightly interconnect the tough adhesive to biologic tissue, even in challenging wet environments like the oral cavity.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Alachua, Florida
- Phone
- (844)281-3169
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- amendsurgical.com
- HQ
- Alachua, Florida
Amend Surgical, Inc. Questions
Amend Surgical, Inc.'s helpline number is (844)281-3169
Amend Surgical, Inc.'s website is amendsurgical.com
Amend Surgical, Inc.'s LinkedIn profile is https://www.linkedin.com/company/amend-surgical-inc.
Amend Surgical, Inc. has
13 employees.
View email and phone details for 13
employees at Amend Surgical, Inc..
Amend Surgical, Inc.'s industry is
Biotechnology Research
Amend Surgical, Inc.'s top competitors are
Vanquish Bio,
Imaginostics,
Targa Biomedical,
Axogen,
Eder Therapeutics,
3daughters,
Azome Therapeutics,
Kaida Biopharma,
Ziptek Llc,
Evergen.
Amend Surgical, Inc.'s categories are Biotechnology Research
Amend Surgical, Inc.'s founding year is 2015
